Literature DB >> 14690422

Caveolin-1 null (-/-) mice show dramatic reductions in life span.

David S Park1, Alex W Cohen, Philippe G Frank, Babak Razani, Hyangkyu Lee, Terence M Williams, Madhulika Chandra, Jamshid Shirani, Andrea P De Souza, Baiyu Tang, Linda A Jelicks, Stephen M Factor, Louis M Weiss, Herbert B Tanowitz, Michael P Lisanti.   

Abstract

Caveolae are 50-100 nm flask-shaped invaginations of the plasma membrane found in most cell types. Caveolin-1 is the principal protein component of caveolae membranes in nonmuscle cells. The recent development of Cav-1-deficient mice has allowed investigators to study the in vivo functional role of caveolae in the context of a whole animal model, as these mice lack morphologically detectable caveolae membrane domains. Surprisingly, Cav-1 null mice are both viable and fertile. However, it remains unknown whether loss of caveolin-1 significantly affects the overall life span of these animals. To quantitatively determine whether loss of Cav-1 gene expression confers any survival disadvantages with increasing age, we generated a large cohort of mice (n = 180), consisting of Cav-1 wild-type (+/+) (n = 53), Cav-1 heterozygous (+/-) (n = 70), and Cav-1 knockout (-/-) (n = 57) animals, and monitored their long-term survival over a 2 year period. Here, we show that Cav-1 null (-/-) mice exhibit an approximately 50% reduction in life span, with major declines in viability occurring between 27 and 65 weeks of age. However, Cav-1 heterozygous (+/-) mice did not show any changes in long-term survival, indicating that loss of both Cav-1 alleles is required to mediate a reduction in life span. Mechanistically, these dramatic reductions in life span appear to be secondary to a combination of pulmonary fibrosis, pulmonary hypertension, and cardiac hypertrophy in Cav-1 null mice. Taken together, our results provide the first demonstration that loss of Cav-1 gene expression and caveolae organelles dramatically affects the long-term survival of an organism. In addition, aged Cav-1 null mice may provide a new animal model to study the pathogenesis and treatment of progressive hypertrophic cardiomyopathy and sudden cardiac death syndrome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14690422     DOI: 10.1021/bi0356348

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  52 in total

Review 1.  The regulation of endothelial nitric oxide synthase by caveolin: a paradigm validated in vivo and shared by the 'endothelium-derived hyperpolarizing factor'.

Authors:  Chantal Dessy; Olivier Feron; Jean-Luc Balligand
Journal:  Pflugers Arch       Date:  2010-03-26       Impact factor: 3.657

Review 2.  Non-canonical roles for caveolin in regulation of membrane repair and mitochondria: implications for stress adaptation with age.

Authors:  Jan M Schilling; Hemal H Patel
Journal:  J Physiol       Date:  2015-10-14       Impact factor: 5.182

3.  Distribution of caveolin-1 and connexin43 in normal and injured alveolar epithelial R3/1 cells.

Authors:  K Barth; M Gentsch; R Bläsche; A Pfüller; I Parshyna; R Koslowski; G Barth; M Kasper
Journal:  Histochem Cell Biol       Date:  2004-11-20       Impact factor: 4.304

4.  Do studies in caveolin-knockouts teach us about physiology and pharmacology or instead, the ways mice compensate for 'lost proteins'?

Authors:  P A Insel; H H Patel
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

5.  Inhibition of renal caveolin-1 reduces natriuresis and produces hypertension in sodium-loaded rats.

Authors:  John J Gildea; Brandon A Kemp; Nancy L Howell; Robert E Van Sciver; Robert M Carey; Robin A Felder
Journal:  Am J Physiol Renal Physiol       Date:  2011-02-02

Review 6.  Caveolae as organizers of pharmacologically relevant signal transduction molecules.

Authors:  Hemal H Patel; Fiona Murray; Paul A Insel
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

7.  Re: Lai HH, Boone TB, Thompson TC, et al: Using caveolin-1 knockout mouse to study impaired detrusor contractility and disrupted muscarinic activity in the aging bladder. Urology 69: 407-411, 2007.

Authors:  George A Kuchel
Journal:  Urology       Date:  2008-03-03       Impact factor: 2.649

8.  Directed evolution and biophysical characterization of a full-length, soluble, human caveolin-1 variant.

Authors:  Joshua N Smith; Joshua M Edgar; J Mark Balk; Mariam Iftikhar; Jessica C Fong; Tivoli J Olsen; Dmitry A Fishman; Sudipta Majumdar; Gregory A Weiss
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2018-05-29       Impact factor: 3.036

9.  The function of alpha- and beta-adrenoceptors of the saphenous artery in caveolin-1 knockout and wild-type mice.

Authors:  S Neidhold; B Eichhorn; M Kasper; U Ravens; A J Kaumann
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

Review 10.  Membrane rafts and caveolae in cardiovascular signaling.

Authors:  Paul A Insel; Hemal H Patel
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-01       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.